𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Docetaxel as a vital option for corticosteroid-refractory prostate cancer

✍ Scribed by Haruki Kume; Motofumi Suzuki; Tetsuya Fujimura; Hiroshi Fukuhara; Yutaka Enomoto; Hiroaki Nishimatsu; Akira Ishikawa; Yukio Homma


Book ID
106555665
Publisher
Springer Netherlands
Year
2011
Tongue
English
Weight
219 KB
Volume
43
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Evidence of a novel docetaxel sensitizer
✍ Edward W. Howard; Davy T. Lee; Yung Tuen Chiu; Chee Wai Chua; Xianghong Wang; Yo πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 770 KB

## Abstract The recent introduction of docetaxel in the treatment of hormone refractory prostate cancer (HRPC) has made a small but significant impact on patient survival. However, its effect is limited by intolerance and resistance. The aim of our study was to investigate if the garlic‐derived com